Aleeto(Aleeto) - _专利_临床

概要

基本信息

药物类型

外泌体药物

别名-

靶点-

作用方式-

作用机制-

治疗领域-

在研适应症-

非在研适应症-

原研机构

北京天坛医院

在研机构-

非在研机构-

权益机构-

最高研发阶段-

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

4

项与 Aleeto 相关的临床试验

NCT06759753

/ Not yet recruiting临床2期IIT

Aleeto in Acute ISchemic Stroke：A RandomISed Controlled Clinical Trial

This study is a prospective, double-blind, 1:1:1 randomized controlled study aimed at evaluating the efficacy and safety of Aleeto treatment compared to placebo in improving the NIHSS score at 14 days in patients with moderate to severe acute ischemic stroke. It also aims to explore the neuroprotective effects of Aleeto in moderate to severe acute ischemic stroke and provide data support and evidence for future clinical trials and evidence-based medicine.

开始日期2025-03-15

申办/合作机构

首都医科大学附属北京天坛医院

NCT06765733

/ Not yet recruiting早期临床1期IIT

The Study of Safety and Preliminary Efficacy of Aleeto in Patients with MultIple System Atrophy

This is a single-center, prospective, randomized, open-label, blinded outcome assessment (PROBE) study. At the end of the PROBE study, patients who have completed the study may opt to enter the open-label extension (OLE) study. The objective of the study is to evaluate the safety, tolerability and potential preliminary efficacy of Aleeto in the treatment of patients with multiple system atrophy (MSA).

开始日期2024-12-31

申办/合作机构

首都医科大学附属北京天坛医院

ChiCTR2400082310

/ Suspended临床1期IIT

Single-arm, open-label, single-center clinical trial of the safety and preliminary efficacy of ALEETO in the treatment of mild to moderate Alzheimer's disease

开始日期2024-03-26

申办/合作机构-

100 项与 Aleeto 相关的临床结果

登录后查看更多信息

100 项与 Aleeto 相关的转化医学

登录后查看更多信息

100 项与 Aleeto 相关的专利（医药）

登录后查看更多信息

100 项与 Aleeto 相关的药物交易

登录后查看更多信息